Inflammatory fluctuations may repeatedly activate nuclear factor kappa B and delay skin repair
In a co-culture of keratinocytes, fibroblasts and macrophages, fluctuating inflammation may repeatedly activate nuclear factor kappa B (NF-κB), prolonging skin growth. Reject this if variability below the activation threshold leaves repeat activations unchanged, or changing them does not affect repair completion.
Stage of verification
- Hypothesis published2026-09-25
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
The biological function description is being prepared
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Signalling pathway
NF-κB activation
Activation of the nuclear factor NF-κB within an intracellular inflammatory cascade
Where this hypothesis actsLocal immune cells after a sleep shift, during repeated treatments timed to epidermal rhythms
Hypotheses on this target 1
Inhibition1
Activation
Desensitisation
Function preservation
Feedback restoration
Rhythm restoration

What is proposed
Inhibition
Reduce the probability of repeated NF-κB activation between treatments
With whatChange of environment or regimen
HowChoose treatment timing using individually estimated probabilities of inflammatory reactivation rather than average intertissue phase delays alone
Possible result
Possible reduction in persistent inflammation, residual dermal proliferation and incomplete repair
From the recordдля устойчивости SPV_6 требуется ограничить вероятность повторного запуска воспаления.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Skin repair may finish less completely when treatments arrive before the effects of earlier treatments have settled. The unexpected move is that an inflammatory response could end normally each time, yet repeated fresh starts could keep repair unfinished. This is a proposal generated by the pipeline, not a measured result: treatment timing would need to account for the chance of another inflammatory restart, beyond average differences between tissue clocks.
- A shift in sleep timing is proposed to place treatment timed to the outer skin layer within a period when local immune cells respond more readily.
- Weak inflammatory signals fluctuate, occasionally pushing internal cell activity above the level that triggers NF-κB.
- Each activation ends and the trigger resets; the proposed change is from an ended response that stays quiet to an ended response followed by fresh brief activations.
- Fresh activations repeatedly renew inflammation and sustain growth in the deeper skin layer.
- Restarts between treatments are proposed to increase the accumulation of unfinished repair.
- Scheduling treatments by the estimated chance of a restart is predicted to improve completion of repair compared with scheduling by average tissue-clock delays alone.
A motion-sensitive light can switch off properly after every activation yet keep a room lit for much of the night if small movements repeatedly switch it back on. The problem lies in fresh triggers, even though the switch-off works.
Where the picture breaks: The picture explains separate restarts but does not establish that inflammatory activity has the proposed trigger-and-reset behavior, that sleep timing changes its sensitivity, or that repeated activation delays skin repair.
- Master questionstep 01 of 04
The goal is a therapy that brings the functional condition of middle-aged people's skin closer to that of young people's skin.
Rests on: The supplied goal explicitly names younger skin function as the intended outcome; it does not report that this outcome has been achieved.
Stated in the chain - Goal pillarstep 02 of 04
The chosen focus is how regeneration, the rebuilding of damaged tissue, limits itself across repeated rounds of repair.
Rests on: This narrows the broad goal of improving skin function to the control of repeated repair.
LeapThe goal does not supply evidence that limits on repeated regeneration explain the functional difference between middle-aged and young skin, or that changing those limits would close that difference.
- Gap questionstep 03 of 04
After a shift in sleep timing, scheduling treatment by the daily clock of the epidermis, the skin's outer layer, might increase its timing mismatch with the dermis, the supporting layer beneath it, and immune cells, which help regulate defense and inflammation. The question is whether accounting for delays between these tissue clocks prevents unfinished repair from accumulating.
Rests on: Repeated repair supplies the concern about accumulation, but the preceding stage does not identify sleep timing or differences between tissue clocks as its cause.
LeapThe supplied material does not establish that treatment timed to the outer skin layer after a sleep shift worsens coordination between tissues, or that correcting their average timing differences prevents unfinished repair.
- Hypothesisstep 04 of 04
Random fluctuations in inflammatory signals are proposed to trigger separate, repeated activations of nuclear factor kappa B, abbreviated NF-κB, a regulator that controls the activity of genes involved in inflammation. Each response would end, but new responses would sustain inflammation and growth in the deeper skin layer. The proposed scheduling target is therefore the probability of another restart between treatments.S3
Rests on: S3, published in Oxidative Medicine and Cellular Longevity in 2020, suggested possible greater readiness for NF-κB reactivation in cultured human keratinocytes, cells of the outer skin layer, after ozone exposure. Its reported measurements could not distinguish NF-κB inside the cell nucleus from NF-κB outside it; it does not establish random restarts in immune cells after a sleep shift or their effect on skin repair. The hypothesis extends that possibility using a mathematical model in which fluctuating activity reaches a trigger level, resets and temporarily becomes unable to trigger again.
Supported by literature
What is carried, and what is not. Of the six proposed mechanism links, one has a directly relevant partial precedent: the possibility of renewed NF-κB activation described by S3, with the cell-type, exposure and measurement limits stated above. Other supplied sources provide background, but none establishes the complete sequence from shifted sleep through repeated inflammatory restarts to unfinished repair or improved treatment scheduling.S3
Where the reasoning is carried by something unstated · 2
- Goal pillar. The goal does not supply evidence that limits on repeated regeneration explain the functional difference between middle-aged and young skin, or that changing those limits would close that difference. Establish the missing link before relying on this step.
- Gap question. The supplied material does not establish that treatment timed to the outer skin layer after a sleep shift worsens coordination between tissues, or that correcting their average timing differences prevents unfinished repair. Establish the missing link before relying on this step.
How a result here could mislead · 3
- A culture could appear to produce random restarts because different cells have consistently different sensitivities, or because one prolonged response is counted as several separate responses. What closes it: Follow the same cells across repeated exposures, confirm a regime where the mean input is below the activation threshold, and define a separate activation before counting events. Measure return toward the inactive state and the temporary interval during which another response cannot start. The specification explicitly requires separating stable differences between cells from randomness within each cell's repeated responses.
- Changing signal variability could also change total inflammatory exposure, tissue-clock timing or the rival mechanism's growth restraint, making an effect look specific to random inflammatory restarts. What closes it: The comparison must match measured tissue-clock timing, total local cytokine exposure, meaning accumulated exposure to cell-to-cell signaling proteins, and the state of primary cilia, small cell projections proposed by the rival to restrain renewed cell division. Match treatment count, total treatment exposure and observation time when comparing schedules. The specification requires these comparisons but does not provide a complete measurement protocol.
- More NF-κB activations alongside continued cell division could be read as proof that the activations prevent repair from finishing, even if both respond to another cause or cell division changes without repair completion changing. What closes it: Measure repair completion alongside activation counts and residual cell division, with completion criteria fixed before testing. A causal test must change the restarts and establish whether completion changes under the matched conditions; the supplied specification does not identify an intervention that isolates this effect or define the completion criteria.
What would make this wrong. The proposed mechanism would fail if, after confirming the below-threshold operating regime and separating stable cell differences from within-cell randomness, changing inflammatory-input variability did not change separate NF-κB restarts, or if changing those restarts did not change repair completion. These are the hypothesis's stated failure conditions; merely failing to alter the intended input would not establish either one.
What it would change. If the hypothesis held, repeated skin treatments would need to account for the chance of inflammatory restarts between procedures, even when average tissue-clock delays were known. Work toward younger skin function would therefore need to test whether schedules based on that probability improve completion of repeated repair. A first result in a shared culture of skin and immune cells would still not establish the effect of an actual sleep shift, lasting benefits in intact middle-aged human skin, or restoration to young people's functional condition; the supplied input also leaves its named scheduling target undefined.
Sources read · 9
Sleep deprivation and the skin. · Clinical and experimental dermatology · 2023
“The focus of our review article is to explore the bidirectional relationship between sleep and cutaneous disease investigating the disruption in circadian rhythmicity and skin homeostasis.”
Does not settle: Источник не устанавливает повторную активацию NF-κB, пороговые события, возбудимость местных иммунных клеток, задержку заживления или вероятность воспалительных запусков между процедурами.
“This study reveals that chronic sleep deprivation disrupts estradiol circadian rhythms, resulting in compromised epidermal barrier function and diminished dermal collagen synthesis.”
Does not settle: It does not assess NF-κB activation, repeated inflammatory reactivation, local immune-cell excitability, event probabilities between procedures, or repair scheduling.
Circadian Clock and OxInflammation: Functional Crosstalk in Cutaneous Homeostasis. · Oxidative medicine and cellular longevity · 2020
“This data further indicated the possibility that the cells are more prone to reactivate NF- κ B (nuclear translocation) in the eventuality of a further challenge. Indeed at this time, it is not possible to discriminate between NF- κ B nuclear and cytoplasmic levels.”
Does not settle: Источник изучал культуру человеческих кератиноцитов после воздействия озона. Остаются открытыми связь со сдвигом сна, повторные случайные активации NF-κB, воспаление и восстановление кожи, а также вероятность событий между процедурами и требования к расписанию SPV_6.
Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. · Frontiers in immunology · 2022
“TIR-domain-containing adaptor-inducing interferon-β (dependent on TRIF) can be recruited and then activates TRAF6, and IκBs (especially IκBα) can degrade leading to the release of NF-κB (P50/65) and its translocation to the nucleus, which can promote the M1 polarization.”
Does not settle: This source does not establish sleep-shift effects, epidermal or skin repair outcomes, repeated or stochastic NF-κB reactivation, event probabilities between procedures, or any scheduling threshold for SPV_6.
NF-κB in monocytes and macrophages - an inflammatory master regulator in multitalented immune cells. · Frontiers in immunology · 2023
“Moreover, recent findings highlighted the temporal dynamics of myeloid NF-κB activation and underlined the complexity of this inflammatory master regulator.”
Does not settle: This review excerpt does not establish effects of sleep shifts, epidermis-localized exposure, repeated NF-κB reactivation thresholds, probabilities between procedures, or delayed skin repair.
Polarized Macrophages in Periodontitis: Characteristics, Function, and Molecular Signaling. · Frontiers in immunology · 2021
“LPS-induced polarization of M1 depends on activation of NF-κBp65, and treatment with IκB kinase-β inhibitors reduces M1-labeled mRNA expression ( ).”
Does not settle: Источник не устанавливает влияние сдвига сна, эпидермально привязанного воздействия, случайных или повторных активаций NF-κB, вероятности событий между процедурами либо задержки восстановления кожи. Описываются сигнальные пути макрофагов при периодонтите.
O-GlcNAcylation dictates pyroptosis. · Frontiers in immunology · 2024
“NF-κB acts as a pivotal mediator in initiating the priming signal required for NLRP3 inflammasome activation, orchestrating the transcriptional upregulation of NLRP3 and pro-IL-1β in response to various pattern recognition receptors (PRRs) ligands and cytokines ( , ).”
Does not settle: Источник не устанавливает связь сдвига сна с эпидермальными иммунными клетками, повторной активацией NF-κB, вероятностным порогом таких событий, заживлением кожи или интервалами между процедурами.
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
“Key pathways include PI3K/Akt and MAPK, which promote fibroblast proliferation, collagen synthesis, and angiogenesis; TGF-β signaling, which orchestrates extracellular matrix remodeling; and NF-κB inhibition, which regulates inflammation resolution (Table ).”
Does not settle: This review does not establish effects of sleep shifts, epidermis-bound exposure, local immune-cell excitability, stochastic NF-κB reactivation, repeated activation probabilities between procedures, dermal growth, or an SPV_6 scheduling threshold.
Circadian Rhythm-Regulated ADSC-Derived sEVs and a Triphasic Microneedle Delivery System to Enhance Tendon-to-Bone Healing. · Advanced materials (Deerfield Beach, Fla.) · 2024
“Herein, the circadian rhythm of adipose-derived stem cells is modulated to increase the yield and enhance the inflammatory regulatory capacity of sEVs.”
Does not settle: Источник не устанавливает влияние сдвига сна на эпидермальные иммунные клетки, повторную активацию NF-κB, вероятностные пороги между процедурами или заживление кожи. Исследование описывает сухожильно-костное соединение в модели восстановления ротаторной манжеты у крыс.
The gap this hypothesis explains
Something is claimed here, but it rests on evidence too thin to carry weight.
Does timing treatment by skin-surface clocks worsen tissue mismatches, and can accounting for delays prevent unfinished repair?
Original wording · exactly as the pipeline generated it
Может ли выбор времени лечения по эпидермальным часам усиливать рассогласование с дермой и иммунными клетками после сдвига сна, и предотвращает ли учёт межтканевых задержек накопление незавершённого восстановления?
What this question is asking
The question concerns whether the daily timing of the skin’s outer layer is a reliable guide for scheduling treatment after sleep timing changes. It asks whether following that layer’s clock could put treatment ahead of the readiness of the deeper skin layer and immune cells, which participate in defense and repair. It then asks whether a schedule that accounts for timing differences between these tissues prevents unfinished repair from accumulating over weeks or months, compared with a schedule based only on the outer layer. This assumes that differences between tissue clocks reflect differences in readiness for treatment and that repeated treatment before all tissues are ready could leave repair unfinished; the supplied sources do not establish those links.
- Epidermis
- The skin’s outer layer, called the skin surface or outer layer in this explanation. S4 estimates daily clock timing from a sample of this layer.
- Dermis
- The skin layer beneath the epidermis. The question asks whether its readiness for treatment can differ from the timing indicated by the outer layer.
- Immune cells and immune signaling
- Immune cells participate in defense and tissue repair; immune signaling is the communication that regulates their activity. These terms cover many cell types and signals, rather than one uniform repair state.
- Circadian clock, circadian phase, and clock oscillations
- A circadian clock is a biological timing system with a cycle of roughly one day. Phase means the position within that cycle, while oscillations are the recurring rises and falls in measured activity. Knowing phase does not by itself establish readiness for treatment.
- Tissue timing mismatches and delays
- These describe differences in the timing of biological cycles across tissues. The question proposes that such differences could affect coordinated repair, but a clock difference is not automatically evidence of harmful disagreement.
- ZeitZeiger and biomarkers
- ZeitZeiger is the analysis method named in S4 for estimating daily clock timing from biological measurements. Biomarkers are measurable biological features used to indicate a condition or process; here, they indicate epidermal clock timing.
- Treatment readiness and unfinished repair
- Treatment readiness means the state in which a tissue could respond appropriately to the proposed treatment. Unfinished repair means repair activity or damage left unresolved between treatment periods. Neither has a specified measurement in the supplied material.
- Fibroblasts, glioma cells, and neurons
- Fibroblasts are cells that help produce and maintain tissue structure; glioma cells are brain-tumor cells; neurons are nerve cells. S3 uses these different cell types as models for studying biological clocks, rather than measuring coordinated repair across intact skin.
- Sleep restriction, sleep deprivation, and a sleep-timing shift
- Sleep restriction reduces available sleep; sleep deprivation involves losing sleep; a sleep-timing shift changes when sleep occurs. These conditions can overlap, but findings about sleep loss do not automatically establish effects of changed sleep timing.
- Skin barrier function
- The skin’s ability to act as a protective boundary between the body and its surroundings. S6 reports damage to this function in mice.
- Oxidative stress
- A condition in which reactive chemicals overwhelm cellular protection and can damage cell components. S6 reports this form of skin damage after sleep restriction.
- Nicotine
- A biologically active substance examined alongside sleep deprivation in S9. Its presence is part of that study’s context, not an established explanation for the proposed tissue-clock mismatch.
- Cell adhesion molecules and inflammation
- Cell adhesion molecules help cells attach to other cells or surrounding structures. Inflammation is a response to injury or threat that can participate in repair; measurements related to both were among the outcomes assessed in S8.
- Gut–brain–skin connections
- A collective name for interactions linking the digestive system, brain, and skin. S5 discusses disruption of these interactions, rather than directly comparing the clocks of different skin tissues.
Epidermal clock timing can be estimated, but after a sleep shift it may precede the readiness of the dermis and immune cells; repeated treatment based on epidermal timing may therefore accumulate unfinished repair.
The epidermis is the skin’s outer layer, the dermis is the layer beneath it, and immune cells help defend and repair tissue. The assumption is that their daily clocks can indicate different times of readiness after a change in sleep timing, so treatment timed to the outer layer might arrive too early for the others. If this holds, accounting for those differences could provide a better guide to complete skin repair.
S4 establishes the narrower point that a set of measurements from one human epidermal sample can estimate its daily clock timing to within three hours. It does not establish that this estimate measures treatment readiness, that deeper tissues adjust more slowly after a sleep shift, or that timing treatment this way causes unfinished repair to accumulate. None of the supplied sources directly establishes those additional links. Their absence from this limited set does not show that the proposed mechanism is false.S4
The same question asked without the part nothing read establishes:
- After a change in sleep timing, does treatment scheduled by the human epidermal clock increase timing differences with the dermis and immune cells?
- After a change in sleep timing, does scheduling skin treatment using several tissues’ clock timings reduce unfinished repair compared with using epidermal timing alone?
- Surface-based timing worsens mismatches; accounting for delays prevents unfinished repair Under the proposed mechanism, the outer layer indicates a treatment time before deeper tissues and immune cells are ready, and repeated mismatches leave repair unfinished. Accounting for their delays would then remove a scheduling-related cause of incomplete repair, making the outer-layer clock alone an insufficient guide.
- Surface-based timing worsens mismatches; accounting for delays does not prevent unfinished repair Treatment timing would affect coordination between tissues, but correcting that coordination would not be sufficient to complete repair. A closer match between tissue clocks could therefore not be treated as evidence that unfinished repair had stopped accumulating.
- Surface-based timing does not worsen mismatches The proposed first step, in which following the outer-layer clock increases disagreement between tissues, would not occur under the conditions assessed. Preventing that particular mismatch would then provide no demonstrated explanation for a benefit from a more complex schedule; overall effects on repair would remain a separate question.
A clock measurement could guide treatment only if the time it reports corresponds to a useful time for the processes that treatment affects. If different skin layers become ready at different times, following the outer layer alone could potentially schedule treatment before deeper repair processes are ready. Under the question’s proposed mechanism, repeating that mismatch could leave some repair unfinished, although the read sources do not demonstrate this sequence. Conversely, if these timing differences do not impair repair, treating them as harmful could make scheduling more complicated without an established benefit.
Оценка эпидермальной фазы и межтканевые часы имеют RL-1; адаптивное расписание не располагает проверенными правилами согласования всех слоёв.
В течение недель и месяцев межтканевые задержки остаются допустимыми, остаточная активность не нарастает, коррекция режима практически выполнима.
Неизвестно, улучшает ли привязка к эпидермальным часам восстановление органа при сдвиге сна или систематически опережает готовность других тканей.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
После сдвига сна эпидермально привязанное воздействие может попадать в период повышенной возбудимости местных иммунных клеток. Случайные колебания активности внутриклеточного воспалительного каскада тогда чаще пересекают порог повторной активации ядерного фактора NF-κB. Каждый отдельный ответ завершается, однако новые краткие активации вновь поддерживают воспаление и дермальный рост. Накопление незавершённого восстановления определяется вероятностью таких событий между процедурами. Расписание, учитывающее только средние межтканевые задержки, может оказаться недостаточным: для устойчивости SPV_6 требуется ограничить вероятность повторного запуска воспаления.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Стохастические процессы: модель первого достижения порога процессом Орнштейна–Уленбека с последующим сбросом. dx = −[x − m(t)]dt/τ + √(2D)dW_t; m(t) = m0 + a cos(φI(t)) + g u(t). Здесь t означает время; x представляет нормированную активность внутриклеточного каскада перед запуском NF-κB; m(t) является её текущим равновесным уровнем; m0 задаёт базовый уровень; τ означает время затухания отклонений; D задаёт интенсивность быстрых молекулярных флуктуаций; W_t является стандартным винеровским процессом; a представляет амплитуду циркадной модуляции возбудимости; φI(t) означает измеренную фазу иммунной клетки; u(t) представляет измеренный локальный воспалительный вход; g переводит его в изменение активности каскада. При достижении x = b регистрируется активация: b означает порог, затем x возвращается к уровню x_r и действует рефрактерный интервал r. x_r и r измеряют восстановление тормозящей обратной связи. Проверяемая величина P(T_b < Δ) представляет вероятность первого достижения порога за межпроцедурный интервал Δ; T_b является временем этого достижения. Это приближение кратковременной возбудимости, не предполагающее второго устойчивого клеточного состояния. Параметры оценивают по одиночным воздействиям, затем проверяют на независимых последовательностях повторных воздействий.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При одинаковых измеренных тканевых фазах, состоянии ресничек и интегральной локальной цитокиновой нагрузке изменение вариабельности слабого воспалительного входа должно менять число отдельных повторных активаций NF-κB и остаточную дермальную пролиферацию. В режиме, где средний вход ниже порога, увеличение дисперсии должно повышать вероятность активации. Расписание, выбранное по индивидуально оценённой вероятности повторного запуска, должно превосходить расписание по среднему фазовому отставанию при одинаковых числе процедур, суммарном воздействии и сроке наблюдения. Гипотеза опровергается, если вариабельность не влияет на повторные активации в установленном подпороговом режиме либо если их изменение не влияет на завершение восстановления.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies a directional change in activation probability, a schedule comparison under matched conditions, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Первую проверку можно провести в совместной культуре кератиноцитов, фибробластов и макрофагов с микрофлюидным управлением входным сигналом и визуализацией ядерного NF-κB. Сначала необходимо подтвердить наличие подпорогового режима и измерить повторяемость ответов одних и тех же клеток. Стабильные различия чувствительности между клетками следует отделить от случайности повторных ответов.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При одинаковых измеренных тканевых фазах, состоянии ресничек и интегральной локальной цитокиновой нагрузке изменение вариабельности слабого воспалительного входа должно менять число отдельных повторных активаций NF-κB и остаточную дермальную пролиферацию. В режиме, где средний вход ниже порога, увеличение дисперсии должно повышать вероятность активации. Расписание, выбранное по индивидуально оценённой вероятности повторного запуска, должно превосходить расписание по среднему фазовому отставанию при одинаковых числе процедур, суммарном воздействии и сроке наблюдения. Гипотеза опровергается, если вариабельность не влияет на повторные активации в установленном подпороговом режиме либо если их изменение не влияет на завершение восстановления.
- Rival 01 of 01What would separate them
Synchronized cilium loss may prolong skin growth by removing a brake on cell-cycle re-entry predicts: В реконструированной коже сравнить узкое и широкое распределения фаз фибробластов при одинаковых средней фазе, индивидуальной амплитуде часов, составе клеток, повреждении и суммарном лечении. Проверять фактические цитокиновые профили и дополнительно воспроизводить их в парных культурах. Гипотеза предсказывает, что более широкое распределение фаз уменьшит длительность общей утраты ресничек и остаточную пролиферацию перед следующим циклом. Восстановление ресничек после начальной миграции должно устранить преимущество распределённых фаз, сохраняя исходное рассогласование молекулярных часов. Гипотеза опровергается, если изменение ресничек при подтверждённой специфичности вмешательства не меняет завершение роста, а исход определяется частотой повторных воспалительных импульсов.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.